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A 9-month Mexican-American female has been followed for episodic hypoglycemia first documented in the imnediate postnatal period. Three convulsions occurred with glucose levels (BS) 20 mg%. Physical exam has been normal to date.
A 4 hr. fast resulted in hypoglycemia (30 mg%) and mild lacticacidemia. Basal and stimulated plasma growth hormone, glucagon and cortisol were normal. IV GTT normal; (K = 1.6).
Glucagon increased BS two-fold. Plasma insulin was < 5 uU/ml during hypoglycemia. IV substrate infusion results were: 
the area of confusion to the process of buffering of metabolic change by tissues other than blood. Unlike the red cell, utilization of buffer in the tissues can be clearly dissociated from the change in the absolute value of pH. This dissociation is shown by the following data obtained in experiments with dogs. Intracellular pH of muscle was estimated by the bicarbonate method. When the intracellular pH was lowered by 0.24 units with respiratory acidosis, the full equivalence of the tissue buffer utilization amounted only to 7.5 mEq. On the other hand, with metabolic acidosis, 30 mEq were neutralized in the tissues while the muscle pH decreased a mere 0.04 units. In place of absolute values, metabolic buffering in the tissues relates to change in the gradient of hydrogen ion concentrations across the cell membrane and hence to a unique and undescribed reaction sequence.
Despite the lack of understanding of mechanism, simple rationales meet requirements for clinical diagnosis. Change in the extracellular bicarbonate is proportional to the m e t e bolic disorder in the complete system. Small adjustments provide suitable correction for abnormal tensions of C02: 1.0-1.3 mEq/liter in the bicarbonate concentration for each deviation of 10 nun Hg in the Pco2. (NSF Grant GB 35524). Hypermethionine~nia in a neonate, originally found on mass screening, was not accompanied by homocystinemia, cystathionirr emia, or hypocystinemia. At 6 months, when plasma methionine was 10-20 times normal, hepatic MAE was 5nmoles S-adenosylmethionine (SAM)/mg prot/h (normal mature MAE = 86 f 16; normal 2nd trimester fetal MAE = 26 + 3 ) . Activities of cystathionine synthase, cystathionase and ~5-methyltetrahydrohydrofolate (Me-THF) homocysteine methyltransferase were normal. "Liver funct ion" tests and a battery of serological tests for hepatogenic infectious agents were normal: the infant appeared healthy. Liver was normal by light microscopy, but electron microscopy showed breaks in the outer membranes of the mitochondria and some hyperplasia of smooth endoplasmic reticulum. Serum folate remained high ( > 16 ng/ml) 4 months after 15 mg/day for 3 weks (should clear in 3-4 reeks), suggesting an inabil ity to metabolize Me-THF to THF due to deficiency of SAM, the product of MPE and a cofactor for Me-THF homocysteine methyl transferase. Unequivocal hypersegmentation of polymorphs but no megalo-ovalocytosis of RBC was found. Skin fibroblasts and lymphoid cell lines are growing and will be assayed for MAE. The strikingly low hepatic MAE activity (below fetal) and its persistance to 8 months of age suggests this is a new metabolic disease. REYE'S SYNDROME: A MODEL AND A HYPOTHESIS. Allen M. Glasgow and H. Peter Chase. University of Colorado Medical Center, Department of Pediatrics, Denver, Colorado.
METHIONINE-ACTIVATING ENZYME (MAE) DEFICIENCY
4-Pentenoic acid (P.A.) an analog of hypoglycin, the compound that causes Jamaican vomiting sickness, was given to rats in an attempt to reproduce Reye's syndrome. Twelve rats given a single dose of 200 mg/kg of P.A. intraperitoneally developed hyperventilation, prostration and finally seizures and death. These animals had elevated ammonia (P.A.=162.4 + 32.9 [S.E.M.] vs control [Cl=44.6 5 3.7 ug/100 ml; p <.Ol)and, in fasted rats, hypoglycemia (serum glucose P.A.=95.3 + 14.6 vs C=146.9 2 6.1 mg/100 ml; p C.01). In long-term experiments 15 rats were given 50 mg/kg of P.A. every 4 hours for 10 doses followed by a single dose of 200 mg/kg. Treated rats had enlarged livers (P.A.=7.49 + .35 vs C=5.87 + .16 gm; p <.001) that showed extensive small vacuole fatty degeneration, an elevated SGOT (P.A.=136.1 + 22.6 vs C=66.4 + 7.1 IU; p <.02), an elevated RUN (P.A.=29.7 5 1 . 0 vs C=16.8 + .8; p <.001) and normal bilirubin levels. P.A. (ImM) inhibited palmitate oxidation in rat liver slices 47 + 10%. Evidence indicates the impairment of fatty acid oxidation results in the other metabolic abnormalities caused by P.A. The similarity in clinical and laboratory findings in this animal model, in Jamaican vomiting sickness, and in Reye's syndrome suggests that the pathophysiology, most likely secondary to impaired fatty acid oxidation, may be similar in all three. This model may prove useful for further studies of the pathophysiology and treatment of Reye's syndrome.
